Aptinyx Total Assets 2011-2026 | APTX

Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.

Main categories of assets
Current assets (used within one year):

Cash and cash equivalents
Accounts receivable (amounts owed by customers)
Inventory of goods, raw materials, and supplies
Short-term investments

Non-current assets (used for more than one year):

Fixed assets (buildings, machinery, equipment)
Intangible assets (brands, patents, software)
Long-term investments
Goodwill (reputational value from mergers)

Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.

Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.

Annual Total Assets Aptinyx

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
66.7 M	115 M	151 M	106 M	156 M	97.3 M	18.6 M	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
156 M	18.6 M	101 M

Quarterly Total Assets Aptinyx

2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
48 M	66.7 M	76.2 M	-	107 M	115 M	133 M	134 M	153 M	151 M	151 M	151 M	151 M	106 M	106 M	106 M	106 M	156 M	156 M	156 M	156 M	97.3 M	97.3 M	97.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
156 M	48 M	121 M

Total Assets of other stocks in the Biotechnology industry

Issuer	Total Assets	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	2.03 B	-	2.43 %	$ 254 M	Germany
Acer Therapeutics ACER	11.6 M	-	2.71 %	$ 14 M	USA
Agenus AGEN	314 M	$ 3.27	-1.8 %	$ 1.17 M	USA
Agios Pharmaceuticals AGIO	1.3 B	$ 29.33	-2.98 %	$ 1.7 B	USA
I-Mab IMAB	6.33 B	-	-	$ 866 M	China
Akebia Therapeutics AKBA	377 M	$ 1.26	-3.44 %	$ 324 M	USA
Akari Therapeutics, Plc AKTX	50.6 M	$ 0.24	1.1 %	$ 5.73 B	Britain
Alexion Pharmaceuticals, Inc. ALXN	18.1 B	-	-	$ 40.3 B	USA
Aldeyra Therapeutics ALDX	72.1 M	$ 5.49	0.52 %	$ 330 M	USA
AgeX Therapeutics AGE	12 M	-	-10.17 %	$ 12.2 K	USA
Alector ALEC	293 M	$ 2.26	-7.2 %	$ 233 M	USA
Biophytis SA BPTS	12 M	-	-13.47 %	$ 169 M	France
Aeglea BioTherapeutics AGLE	778 M	-	-	$ 1.01 B	USA
Aligos Therapeutics ALGS	152 M	$ 7.02	-0.21 %	$ 451 M	USA
Alkermes plc ALKS	2.49 B	$ 29.32	-2.61 %	$ 4.83 B	Irlanda
Allogene Therapeutics ALLO	643 M	$ 2.57	-7.73 %	$ 403 M	USA
Applied Genetic Technologies Corporation AGTC	66.7 M	-	-	$ 26.5 M	USA
Alnylam Pharmaceuticals ALNY	4.97 B	$ 330.95	-0.59 %	$ 43.4 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	15.2 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	14.8 M	-	-18.52 %	$ 27.3 M	Britain
Altimmune ALT	139 M	$ 4.2	-2.55 %	$ 298 M	USA
ALX Oncology Holdings ALXO	148 M	$ 2.11	0.09 %	$ 110 M	USA
Amgen AMGN	90.6 B	$ 387.85	0.03 %	$ 209 B	USA
Amphastar Pharmaceuticals AMPH	1.63 B	$ 20.22	-0.05 %	$ 945 M	USA
Amarin Corporation plc AMRN	832 M	$ 13.62	-1.3 %	$ 5.55 B	Irlanda
AIM ImmunoTech AIM	40.5 M	$ 0.92	5.25 %	$ 44.2 M	USA
AnaptysBio ANAB	484 M	$ 54.61	-0.8 %	$ 1.55 B	USA
Anika Therapeutics ANIK	271 M	$ 14.44	0.53 %	$ 212 M	USA
ANI Pharmaceuticals ANIP	1.28 B	$ 75.31	1.91 %	$ 1.45 B	USA
Annexon ANNX	350 M	$ 5.38	-3.93 %	$ 739 M	USA
Annovis Bio ANVS	10.2 M	$ 2.6	-2.99 %	$ 23.5 M	USA
ARCA biopharma ABIO	396 M	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	109 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	72 M	-	4.01 %	$ 150 M	Canada
Adverum Biotechnologies ADVM	180 M	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	1.51 B	-	-	-	Russia
Apellis Pharmaceuticals APLS	1.08 B	$ 20.53	-2.05 %	$ 2.59 B	USA
Aptorum Group Limited APM	16.1 M	$ 0.78	-0.67 %	$ 4.25 M	China
AIkido Pharma AIKI	47.1 M	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	826 M	-	-	$ 3.67 B	USA
Akouos AKUS	279 M	-	0.23 %	$ 488 M	USA
Aprea Therapeutics APRE	22.7 M	$ 0.88	-3.71 %	$ 3.18 M	USA
Aptevo Therapeutics APVO	15.6 M	$ 7.28	-0.55 %	$ 2.01 M	USA
Albireo Pharma ALBO	302 M	-	-0.23 %	$ 916 M	USA
Allena Pharmaceuticals ALNA	34.8 M	-	3.16 %	$ 1.9 M	USA
Aquestive Therapeutics AQST	101 M	$ 3.99	-0.15 %	$ 346 M	USA
Arcturus Therapeutics Holdings ARCT	344 M	$ 8.11	-1.44 %	$ 219 M	Israel
Ardelyx ARDX	502 M	$ 6.32	-3.54 %	$ 1.52 B	USA
Aileron Therapeutics ALRN	62.2 M	-	10.36 %	$ 9.8 M	USA
argenx SE ARGX	6.2 B	$ 762.51	-0.58 %	$ 25 B	Niderland